Aequus Pharmaceuticals (Aequus Pharmaceuticals) Days Sales Outstanding : 50.30 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Aequus Pharmaceuticals Days Sales Outstanding?

Aequus Pharmaceuticals's average Accounts Receivable for the three months ended in Mar. 2024 was $0.02 Mil. Aequus Pharmaceuticals's Revenue for the three months ended in Mar. 2024 was $0.04 Mil. Hence, Aequus Pharmaceuticals's Days Sales Outstanding for the three months ended in Mar. 2024 was 50.30.

The historical rank and industry rank for Aequus Pharmaceuticals's Days Sales Outstanding or its related term are showing as below:

AQSZF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 73.83 Med: 129.76 Max: 244.76
Current: 133.11

During the past 11 years, Aequus Pharmaceuticals's highest Days Sales Outstanding was 244.76. The lowest was 73.83. And the median was 129.76.

AQSZF's Days Sales Outstanding is ranked worse than
86.87% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.69 vs AQSZF: 133.11

Aequus Pharmaceuticals's Days Sales Outstanding declined from Dec. 2022 (70.22) to Mar. 2024 (50.30).

Warning Sign:

If a company's sales outstanding increases, it means it has difficulty collecting payments from its customers.

Aequus Pharmaceuticals Days Sales Outstanding Historical Data

The historical data trend for Aequus Pharmaceuticals's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aequus Pharmaceuticals Days Sales Outstanding Chart

Aequus Pharmaceuticals Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Days Sales Outstanding

Get a 7-Day Free Trial

142.17

92.96

115.64

172.98

242.05

Aequus Pharmaceuticals Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Days Sales Outstanding	Get a 7-Day Free Trial															70.22	310.52	474.50	91.25	50.30

Competitive Comparison of Aequus Pharmaceuticals's Days Sales Outstanding

For the Drug Manufacturers - Specialty & Generic subindustry, Aequus Pharmaceuticals's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Aequus Pharmaceuticals's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Aequus Pharmaceuticals's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Aequus Pharmaceuticals's Days Sales Outstanding falls into.

Aequus Pharmaceuticals Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Aequus Pharmaceuticals's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

	Days Sales Outstanding (A: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2022 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (0.228	+	0.024)	/	2 )	/	0.19	*	365
=	0.126					/	0.19	*	365
=	242.05

Aequus Pharmaceuticals's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding (Q: Mar. 2024 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )	/	Revenue (A: Mar. 2024 )	*	Days in Period
=	( (0.024	+	0.019)	/	2 )	/	0.039	*	365 / 4
=	0.0215					/	0.039	*	365 / 4
=	50.30

Aequus Pharmaceuticals (OTCPK:AQSZF) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Aequus Pharmaceuticals Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Aequus Pharmaceuticals's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Aequus Pharmaceuticals (Aequus Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aequus Pharmaceuticals Inc (OTCPK:AQSZF) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

AEQ:Germany AQS:Canada

Address

200 Granville Street, Suite 2820, Vancouver, BC, CAN, V6C 1S4

Website

https://www.aequuspharma.ca

Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.